References
1. Integraal Kankercentrum Nederland (2020, July 7). Epitheliale eierstokkanker. Retrieved from https://www.iknl.nl/. Epitheliale eierstokkanker (2020).
2. Chan, J. K. et al. Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet. Gynecol. 109, 12–19 (2007).
3. Trimbos, B. et al. Surgical Staging and Treatment of Early Ovarian Cancer : Long-term Analysis From a Randomized Trial. 102, (2010).
4. Trimbos, J. B. et al. Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma : European Organisation for Research and Treatment of Cancer – Adjuvant ChemoTherapy in Ovarian. 95, 113–125 (2003).
5. Prat, J. & Committee, F. International Journal of Gynecology and Obstetrics Staging classi fi cation for cancer of the ovary , fallopian tube , and peritoneum ☆. Int. J. Gynecol. Obstet. 1–5 (2013). doi:10.1016/j.ijgo.2013.10.001
6. Benedet, J. L., Bender, H. & Pecorelli, S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. (2000).
7. Cass, I. et al. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.Gynecol. Oncol. 80, 56–61 (2001).
8. Powless, C. A., Bakkum-Gamez, J. N., Aletti, G. D. & Cliby, W. A. Random peritoneal biopsies have limited value in staging of apparent early stage epithelial ovarian cancer after thorough exploration.Gynecol. Oncol. 115, 86–89 (2009).
9. Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, and Ahmed Elmagarmid. Rayyan — a web and mobile app for systematic reviews. Systematic Reviews (2016) 5:210, D. 10. 1186/s1364.-016-0384-4. Rayyan.
10. Wells, G. A., Shea, B., O’connell, D., Peterson, J., Welch, V., Losos, M., & Tugwell, P. (2016). T. N.-O. S. (NOS) for assessing the quality if nonrandomized studies in meta-analyses. 2009. E. A. from: U. http://www. ohri. ca/programs/clinical_epidemiology/oxford. htm [cited 2020 A. 27]. No Title.
11. Mahdi, H. et al. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma. Int. J. Gynecol. cancer Off. J. Int. Gynecol. Cancer Soc. 23, 1226–1230 (2013).
12. Hengeveld, E. M., Zusterzeel, P. L. M., Lajer, H., Høgdall, C. K. & Rosendahl, M. The value of surgical staging in patients with apparent early-stage epithelial ovarian carcinoma. Gynecol. Oncol. 154, 308–313 (2019).
13. Padhy, R. R., Savage, J. & Kurman, R. J. Comprehensive Surgical Staging in Stage 1 Clear Cell and Endometrioid Ovarian Carcinomas : Is it Necessary ? 241–246 (2018). doi:10.1097/PGP.0000000000000521
14. Lee, J.-Y. et al. The role of omentectomy and random peritoneal biopsies as part of comprehensive surgical staging in apparent early-stage epithelial ovarian cancer. Ann. Surg. Oncol.21, 2762–2766 (2014).
15. Ditto, A. et al. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study. Ann. Surg. Oncol. 19, 3849–3855 (2012).
16. Negishi, H. et al. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Gynecol. Oncol. 94, 161–166 (2004).
17. Mujezinovic, F. Tumor laterality in early ovarian cancer : influence on left-right asymmetry of pelvic. 695–698 (2010).
18. William, F. et al. Staging Laparotomy in Early Ovarian Cancer. (2015).
19. Ayhan, A. et al. Occult metastasis in early ovarian cancers : risk factors and. YMOB 196, 81.e1-81.e6 (2007).
20. Ayhan, A. et al. Routine appendectomy in epithelial ovarian carcinoma: is it necessary? Obstet. Gynecol. 105, 719–724 (2005).
21. faught2003.pdf.
22. Onda, T., Yoshikawa, H., Yokota, H., Yasugi, T., & Taketani, Y. (1996). Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma: a proposal for essential sites for lymph node biopsy. Cancer: Interdisciplinary Internationa. (1996).
23. Garcia-Soto, A. E., Boren, T., Wingo, S. N., Heffernen, T. & Miller, D. S. Is comprehensive surgical staging needed for thorough evaluation of early-stage ovarian carcinoma? Am. J. Obstet. Gynecol. 206, 242.e1–5 (2012).
24. Le, T., Adolph, A., Krepart, G. V, Lotocki, R. & Heywood, M. S. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Gynecol. Oncol. 85, 351–355 (2002).
25. Gouy, S. et al. Gynecologic Oncology Reports Staging surgery in early-stage ovarian mucinous tumors according to expansile and in fi ltrative types. Gynecol. Oncol. Reports 22, 21–25 (2017).
26. Naru, R. R., Hulikal, N., Nandyal, R. & Bodagala, V. Including Para-Aortic Lymph Node Dissection of Presumed Early Stage Epithelial Ovarian Cancer : 33, 184–188 (2017).
27. Mueller, J. J. et al. Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary Upstaging in Clinically Apparent. 26, 120–124 (2016).
28. Minig, L. et al. Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study. Ann. Surg. Oncol. 24, 2720–2726 (2017).
29. Bogani, G. et al. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses. Gynecol. Oncol. 147, 61–65 (2017).
30. Babayeva, A. et al. Clinical Outcome After Completion Surgery in Patients With Ovarian Cancer: The Charite Experience. Int. J. Gynecol. cancer Off. J. Int. Gynecol. Cancer Soc. 28, 1491–1497 (2018).
31. Bachmann, C. et al. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer. Anticancer Res. 34, 6735–6738 (2014).
32. Bacalbasa, N. et al. The Risk of Para-Aortic Lymph Node Metastases in Apparent Early Stage Ovarian Cancer. Medicina (Kaunas). 56, (2020).
33. Suzuki, M. et al. Lymph node metastasis in stage I epithelial ovarian cancer. Gynecol. Oncol. 79, 305–308 (2000).
34. Shroff, R. et al. The utility of peritoneal biopsy and omentectomy in the upstaging of apparent early ovarian cancer.Int. J. Gynecol. cancer Off. J. Int. Gynecol. Cancer Soc. 21, 1208–1212 (2011).
35. Press, E. B. Department Accepted. 13, 303–307 (1982).
36. Schmeler, K. M. et al. Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary. Obstet. Gynecol. 116, 269–273 (2010).
37. Matsuo, K. et al. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer. J. Gynecol. Oncol. 29, (2018).
38. Hoogendam, J. P., Vlek, C. A., Witteveen, P. O., Verheijen, R. H. M. & Zweemer, R. P. Surgical lymph node assessment in mucinous ovarian carcinoma staging: a systematic review and meta-analysis. BJOG An Int. J. Obstet. Gynaecol. 124, 370–378 (2017).
39. Baldwin, L. A. et al. Ten-year relative survival for epithelial ovarian cancer. Obstet. Gynecol. 120, 612–618 (2012).
40. Gmyrek, L. J., Jonska-Gmyrek, J., Sobiczewski, P., Panek, G. & Bidzinski, M. Evaluation of intraoperative and postoperative complications related to lymphadenectomy in ovarian cancer patients.Oncol. Lett. 2, 537–541 (2011).
41. Kim, S. I. et al. Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissection. Eur. J. Obstet. Gynecol. Reprod. Biol. 192, 31–36 (2015).
42. Günakan, E. et al. Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer. Obstet. Gynecol. Sci. 63, 64–71 (2020).
43. Tantitamit, T. & Lee, C.-L. Is It the Time for Laparoscopic Management of Early-stage Ovarian Malignancies? Gynecol. Minim. invasive Ther. 7, 93–103 (2018).
44. Zeff, N. Role of laparoscopy in initial tumour staging in advanced epithelial ovarian cancer: A systematic review. Pleura and Peritoneum 3, (2018).
45. Melamed, A. et al. Cancer : Analysis of the National Cancer Data Base. 216, 1–20 (2018).
46. Kleppe, M. et al. Gynecologic Oncology Lymph node metastasis in stages I and II ovarian cancer : A review. Gynecol. Oncol.123, 610–614 (2011).